A 26-week repeated dose toxicity evaluation of sporoderm-removed Ganoderma lucidum spores in rats
Food and Chemical Toxicology · 2023-12 · 182 · 114175
DOI: 10.1016/j.fct.2023.114175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2023-12. Verfasst von Lijuan Xia und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center of Safety Evaluation and Research, Hangzhou Medical College, Hangzhou, 310053, China; Key Laboratory of Drug Safety Evaluation and Research of…. Hauptthemen laut MEDLINE: Reishi, Ganoderma. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development Program of Zhejiang Province.
Abstract (Originalsprache)
Ganoderma lucidum spore powder is a traditional Chinese medicine with a variety of health benefits. Sporoderm-removed Ganoderma lucidum spores (RGLS) can be more effectively absorbed and utilized by the body. Due to the extensive clinical application and lack of long-term (>30 days) safety evaluation of RGLS, it is necessary to evaluate its repeated dose toxicity during a longer administration period. Here, we conducted a 26-week repeated dose toxicity test of RGLS in Sprague‒Dawley (SD) rats. The male and female rats were orally administered RGLS at doses of 0, 0.4, 1.2, and 4.0 g/kg once daily for a period of 26 weeks. The safety profile of RGLS was assessed through in vivo observations of survival, body weight, and food consumption; hematological, biochemical, and urine analyses; immunotoxicity assays; and histopathological examinations. The results showed that no significant systemic toxicity was observed following 26 weeks of repeated RGLS administration. Our data showed a no-observed adverse effect level (NOAEL) of 4.0 g/kg, which is approximately 20 times higher than the human equivalent dose. Our results support that RGLS can be considered a safe medicinal or food product that can be added to a healthy diet.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Safety Evaluation and Research, Hangzhou Medical College, Hangzhou, 310053, China; Key Laboratory of Drug Safety Evaluation and Research of Zhejiang Province, Hangzhou Medical College (Zhejiang Academy of Medi…
- Center of Safety Evaluation and Research, Hangzhou Medical College, Hangzhou, 310053, China; Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzh…
- Jinhua Shouxiangu Pharmaceutical Co., Ltd., Jinhua, 321299, China.
- Center of Safety Evaluation and Research, Hangzhou Medical College, Hangzhou, 310053, China.
- Jinhua Shouxiangu Pharmaceutical Co., Ltd., Jinhua, 321299, China. Electronic address: zhenhao6@126.com.
Förderung
- Key Research and Development Program of Zhejiang Province
Zitieren
APA
Xia, L., Sun, R., Zhang, L., Li, J., Zhang, C., Yang, Q., Zhang, L., Zhang, S., Wang, H., Lyu, H., Lyu, W., Li, Z., & Zhang, L. (2023). A 26-week repeated dose toxicity evaluation of sporoderm-removed Ganoderma lucidum spores in rats. Food and Chemical Toxicology, 182, 114175. https://doi.org/10.1016/j.fct.2023.114175
Vancouver
Xia L, Sun R, Zhang L, Li J, Zhang C, Yang Q, et al. A 26-week repeated dose toxicity evaluation of sporoderm-removed Ganoderma lucidum spores in rats. Food and Chemical Toxicology. 2023;182:114175. doi:10.1016/j.fct.2023.114175
BibTeX
@article{Xia2023,
author = {Xia, Lijuan and Sun, Ruimin and Zhang, Liyan and Li, Jinrong and Zhang, Chengda and Yang, Qian and Zhang, Lili and Zhang, Siming and Wang, Hanbo and Lyu, Hanying and Lyu, Wanqiang and Li, Zhenhao and Zhang, Lijiang},
title = {A 26-week repeated dose toxicity evaluation of sporoderm-removed Ganoderma lucidum spores in rats},
journal = {Food and Chemical Toxicology},
year = {2023},
volume = {182},
pages = {114175},
doi = {10.1016/j.fct.2023.114175}
}
EUVIMED